A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS

Clinical trial NCT01085656 · TERMINATED

Trial details

NCT number: NCT01085656
Sponsor: University of Florida
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myelogenous, Acute Myelodysplastic Syndromes

Start date: 2011-02-01
Primary completion: 2016-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.